Annoroad Gene Technology

Company Deals

Chinese IVD Firm Annoroad Gene Targets Global Expansion with IPO

Fineline Cube Apr 1, 2025

China-based Annoroad Gene Technology (Beijing) Co., Ltd. has submitted an initial public offering (IPO) filing...

Company Drug

BMS Faces Phase III Setback for Camzyos in Non-Obstructive HCM Study

Company Drug

Beijing Wantai Launches Phase III Trial for 9-Valent HPV Vaccine in Chinese Males

Company Drug

Jiangsu Nhwa Initiates Phase I Trial for NH280105, an Oral Lp-PLA₂ Inhibitor for Alzheimer’s Disease

Company Drug

Hengrui Pharmaceuticals Gains NMPA Clearance for Phase II Study of HRS-7058 in Solid Tumors